Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

The nature of the pathogenesis and of the prolonged immunity of whooping cough has not been clearly defined. The literature of Bordetella pertussis indicated that only the antigen that induces histamine sensitization, lymphocytosis, and other biological reactions in mice is the cause of the harmful effects and prolonged immunity of whooping cough. This antigen has the general characteristics of bacterial protein exotoxins that cause the harmful effects of infectious diseases such as diphtheria and tetanus. It is proposed that this antigen, which is histamine-sensitizing, lymphocyte-leukocyte-promoting, and islets-activating (HSF-LPF-IAP), be designated pertussis toxin. Agglutinogen, hemagglutinin, and heat-labile (at 56 C) and heat-stable (at 100 C) toxins are no doubt interrelated with the immunologic and/or toxic reactions of whooping cough. It appears that the first defense against the disease is the antibody that prevents adhesion of the bacteria to the cilia of the respiratory epithelium and that the second defense is the antitoxin against pertussis toxin (HSF-LPF-IAP).

[1]  M. Pittman,et al.  Evaulation of the potency of antipertussis serum products. , 1979, Journal of biological standardization.

[2]  Loss of adenylate cyclase activity in variants of Bordetella pertussis , 1978 .

[3]  A. Wardlaw,et al.  Loss of heat-labile toxin from Bordetella pertussis grown in modified hornibrook medium , 1978 .

[4]  M. Ui,et al.  Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. , 1978, Journal of biochemistry.

[5]  M. Ui,et al.  Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. , 1978, Journal of biochemistry.

[6]  Y. Kuwajima.  The presence of the heat-stable neurotoxin in the pertussis cells. , 1978, Osaka city medical journal.

[7]  R. Black,et al.  Botulism in the United States, 1976. , 1977, The Journal of infectious diseases.

[8]  T. Matsuyama.  Resistance of Bordetella pertussis phase I to mucociliary clearance by rabbit tracheal mucous membrane. , 1977, The Journal of infectious diseases.

[9]  T. Katada,et al.  Perfusion of the pancreas isolated from pertussis-sensitized rats: potentiation of insulin secretory responses due to beta-adrenergic stimulation. , 1977, Endocrinology.

[10]  D. Bemis,et al.  Pathogenesis of canine bordetellosis. , 1977, The Journal of infectious diseases.

[11]  D. Bemis,et al.  Naturally occurring respiratory disease in a kennel caused by Bordetella bronchiseptica. , 1977, The Cornell veterinarian.

[12]  C. Linnemann,et al.  Pertussis in the adult. , 1977, Annual review of medicine.

[13]  R. K. Bergman,et al.  Bordetella pertussis : immunological and other biological activities , 1977 .

[14]  Y. Sato,et al.  Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. , 1976, Biochimica et biophysica acta.

[15]  A. Kassem,et al.  The beta-adrenergic receptors in pertussis. , 1976, The Journal of tropical medicine and hygiene.

[16]  M. Pittman.  PROTECTIVE ACTIVITY OF WHOOPING-COUGH CONVALESCENT SERUM AND SERUM-IgA LEVEL IN MICE INFECTED WITH BORDETELLA PERTUSSIS , 1976, The Lancet.

[17]  J. Morse,et al.  Isolation and properties of the leukocytosis- and lymphocytosis- promoting factor of Bordetella pertussis , 1976, The Journal of experimental medicine.

[18]  A. Wardlaw,et al.  Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. , 1976, Journal of medical microbiology.

[19]  S. I. Morse.  Biologically active components and properties of Bordetella pertussis. , 1976, Advances in applied microbiology.

[20]  I. McCandlish,et al.  Experimental respiratory disease in dogs due to Bordetella bronchiseptica. , 1976, Research in veterinary science.

[21]  G. Thomas.  Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine , 1975, Journal of Hygiene.

[22]  A. Wardlaw,et al.  Cell-envelope proteins of Bordetella pertussis. , 1975, Journal of medical microbiology.

[23]  J. Ackers,et al.  The effect of the antigen which elicits the bactericidal antibody and of the mouse-protective antiǵen on the growth of Bordetella pertussis in the mouse brain , 1975, Journal of Hygiene.

[24]  Y. Sato,et al.  Leukocytosis-promoting factor of Bordetella pertussis. , 1975, Japanese journal of medical science & biology.

[25]  M. Pittman.  Determination of the histamine sensitizing unitage of pertussis vaccine. , 1975, Journal of biological standardization.

[26]  M. Pittman,et al.  Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. , 1975, Journal of biological standardization.

[27]  Y. Sato,et al.  Leukocytosis-Promoting Factor of Bordetella pertussis III. Its Identity with Protective Antigen , 1974, Infection and immunity.

[28]  M. Pittman,et al.  Immunoglobulin and Histamine-Sensitivity Response of Mice to Live Bordetella pertussis , 1973, Infection and immunity.

[29]  Y. Sato,et al.  Leucocytosis-Promoting Factor of Bordetella pertussis I. Purification and Characterization , 1972, Infection and immunity.

[30]  J. Ackers,et al.  The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice. , 1972, Journal of general microbiology.

[31]  Y. Nakase,et al.  Purified K-agglutinogen of Bordetella pertussis and its properties. , 1971, Japanese journal of microbiology.

[32]  J. Munoz.  CHAPTER 7 – Protein Toxins from Bordetella pertussis , 1971 .

[33]  J. Morse,et al.  STUDIES ON THE ULTRASTRUCTURE OF BORDETELLA PERTUSSIS , 1970, The Journal of experimental medicine.

[34]  G. Eldering,et al.  Bordetella pertussis Serotypes in the United States , 1970, Applied microbiology.

[35]  M. Tateishi,et al.  Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis. , 1969, Japanese journal of microbiology.

[36]  C. Linnemann,et al.  The carrier state in pertussis. , 1968, American journal of epidemiology.

[37]  I. Tabachnick,et al.  Metabolic effects of pertussis sensitization in mice and rats. , 1968, Endocrinology.

[38]  E. Ribi,et al.  Reaction of Endotoxin and Surfactants I. Physical and Biological Properties of Endotoxin Treated with Sodium Deoxycholate , 1966, Journal of bacteriology.

[39]  J. Craig.  A Permeability Factor (Toxin) Found in Cholera Stools and Culture Filtrates and its Neutralization by Convalescent Cholera Sera , 1965, Nature.

[40]  S. Iwasa,et al.  On a possible new kind of toxic substance produced by Bordetella pertussis. , 1965, Japanese journal of medical science & biology.

[41]  J. Dolby,et al.  Characterization of the antibodies responsible for the 'bactericidal activity patterns' of antisera to Bordetella pertussis. , 1965, Immunology.

[42]  J. Munoz.  SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF BORDETELLA PERTUSSIS ANTIGENS. , 1963, Bacteriological reviews.

[43]  J. Munoz,et al.  Antigens of Bordetella pertussis.III. The Protective Antigen , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  M. Niwa.  Histamine sensitizing factor of Bordetella pertussis. , 1962, Journal of biochemistry.

[45]  Y. Yamamura,et al.  CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS I , 1961, Journal of bacteriology.

[46]  Z. Pusztai,et al.  Comparative investigations into the mouse-protective potency, histamine-sensitizing activity and agglutinin-producing ability of pertussis vaccines. , 1961, Zeitschrift fur Immunitatsforschung und experimentelle Therapie.

[47]  Z. Pusztai,et al.  Histamine-sensitizing activity of various pertussis vaccines. , 1961, Zeitschrift fur Immunitatsforschung und experimentelle Therapie.

[48]  B. Lacey.  Antigenic modulation of Bordetella pertussis , 1960, Journal of Hygiene.

[49]  E. Ribi,et al.  Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm. , 1959, Journal of immunology.

[50]  L. S. Kind.  The altered reactivity of mice after inoculation with Bordetella pertussis vaccine. , 1958, Bacteriological reviews.

[51]  H. B. Maitland,et al.  Some surface components of Haemophilus pertussis: immunising antigen, histamine-sensitising factor and agglutinogen. , 1958, The Journal of pathology and bacteriology.

[52]  J. Dolby,et al.  A comparison of passive protection tests against intranasal and intracerebral challenges with Bordetella pertussis. , 1958, Immunology.

[53]  A. F. Standfast.  The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis. , 1958, Immunology.

[54]  M. Pittman.  Effect of Haemophilus pertussis on immunological and physiological reactions. , 1957, Federation proceedings.

[55]  G. Eldering,et al.  SEROLOGICAL STUDY OF BORDETELLA PERTUSSIS AND RELATED SPECIES , 1957, Journal of bacteriology.

[56]  H. M. Felton.  Pertussis; current status of prevention and treatment. , 1957, Pediatric clinics of North America.

[57]  D. Rankin,et al.  Immunization of children against whooping-cough with pertussis haemagglutinin (H.A.P.A.): field results over three years. , 1956, The Medical journal of Australia.

[58]  I. Lepow,et al.  PROTECTIVE ANTIGEN OF HÆMOPHILUS PERTUSSIS , 1954 .

[59]  E. K. Andersen.  Serological studies on H. pertussis H. parapertussis and H. bronchisepticus. , 2009, Acta pathologica et microbiologica Scandinavica.

[60]  J. L. Winter,et al.  Development of Antibodies in Children Convalescent from Whooping Cough.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[61]  F. Masry.  Production, Extraction and Purification of the Haemagglutinin of Haemophilus pertussis , 1952 .

[62]  M. Pittman.  Comparison of the histamine sensitizing property with the protective activity of pertussis vaccines for mice. , 1951, The Journal of infectious diseases.

[63]  J. Gordon,et al.  Whooping cough and its epidemiological anomalies. , 1951, The American journal of the medical sciences.

[64]  M. Warburton,et al.  The haemagglutinin of Haemophilus pertussis. III. Extraction of the antigen from the bacteria and its stabilization by adsorption. , 1951, The Australian journal of experimental biology and medical science.

[65]  M. Pittman.  Sensitivity of Mice to Histamine During Respiratory Infection by Hemophilus pertussis. , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[66]  L. Pillemer.  Adsorption of Protective Antigen of Hemophilus Pertussis on Human Red Cell Stromata.∗ , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[67]  S. Fisher.  THE HAEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS , 1950 .

[68]  E. North,et al.  The haemagglutinin of Haemophilus pertussis; haemagglutinin as a protective antigen in experimental murine pertussis. , 1948, The Australian journal of experimental biology and medical science.

[69]  I. Parfentjev,et al.  Histamine shock in mice sensitized with Hemophilus pertussis vaccine. , 1948, The Journal of pharmacology and experimental therapeutics.

[70]  M. Warburton,et al.  Hæmagglutinins of the Hæmophilus Group , 1947, Nature.

[71]  D. Evans.  The failure of whooping-cough and adult sera to neutralise pertussis toxin. , 1947, The Journal of pathology and bacteriology.

[72]  L. Cravitz,et al.  PERTUSSIS IMMUNIZATION PROGRAM OF THE BOSTON HEALTH DEPARTMENT: THE COMPARATIVE VALUE OF TWO DIFFERENT ANTIGENS , 1945 .

[73]  J. G. Armstrong,et al.  Hyperimmune whooping cough serum , 1944 .

[74]  M. E. Roberts,et al.  Pertussis Toxin-Antitoxin Neutralization Technic , 1944 .

[75]  John J H Miller,et al.  An agglutinative reaction for hemophilus pertussis: II. Its relation to clinical immunity , 1943 .

[76]  E. North,et al.  The Relation of Pertussis Endotoxin to Pertussis Immunity in the Mouse. , 1943 .

[77]  E. North,et al.  ACTIVE IMMUNIZATION BY THE INTRANASAL ROUTE IN EXPERIMENTAL PERTUSSIS , 1942 .

[78]  M. Siegel,et al.  A STUDY OF PERTUSSIS ANTIBODIES: PROTECTIVE, AGGLUTINATING AND COMPLEMENT-FIXING ANTIBODIES IN PATIENTS WITH PERTUSSIS, PERSONS EXPOSED TO PERTUSSIS AND PERSONS WITH NO KNOWN EXPOSURE , 1942 .

[79]  H. Scherp,et al.  EFFECT OF REFINED ANTIPERTUSSIS RABBIT SERUM ON THE HUMORAL ANTIBODY TITER IN PERTUSSIS , 1941 .

[80]  D. Evans.  The production of pertussis antitxin in rabbits and the neutralisation of pertussis, parapertussis and bronchiseptica toxins , 1940 .

[81]  E. North,et al.  PASSIVE IMMUNITY IN EXPERIMENTAL PERTUSSIS , 1939 .

[82]  H. B. Maitland,et al.  The toxin of Br. bronchiseptica and the relationship of this organism to H. pertussis , 1939 .

[83]  F. Burnet,et al.  Experimental Infection with Hæmophilus pertussis in the Mouse by Intranasal Inoculation , 1937 .

[84]  G. Mannerstedt.  Pertussis in adults , 1934 .

[85]  L. Rhea.  The Comparative Pathology of the tracheal and bronchial Lesions produced in Man by B. Pertussis (Whooping-Cough) and those produced in Dogs by B. Bronchisepticus (Canine Distemper). , 1915, The Journal of medical research.

[86]  J. Bordet,et al.  L'endotoxine coquelucheuse , 1909 .